| 1 | Effect of maternal diabetes during pregnancy on placental epigenetics and its association with retinal development and risk of retinopathy in infants | Wellcome Trust India Alliance early career fellowship | 2024-2029 | Dr Aatish Mahajan |
| 2 | Impact of Urban Air Pollution on ocular surface microbiome changes and its effect on dry eye disease | Indian Council of Medical Research | 2021-2025 | Dr Arunasri Kotakonda |
| 3 | Mitochondrial Association with Transcriptomic Signatures for Trabecular Meshwork Damage in Glaucoma: A tissue-specific omics approach
| Indian Council of Medical Research | 2025-2027 | Dr Aparna Rao |
| 4 | Setting up pathogen surveillance systems beyond SARS-CoV2 | Rockefeller Foundation | 2022-2025 | Dr Bhupesh Bagga
|
| 5 | Role of TRP ion channels in regulating corneal endothelial response to increased intraocular pressure | Science and Engineering Research Board | 2023-2026 | Dr Charanya Ramachandran |
| 6 | Silk Fibroin carrier for the culture and transplantation of corneal endothelium | Department of Biotechnology
| 2024-2027 | Dr Charanya Rmachandran |
| 7 | Identification of diagnostic biomarkers in vitreous/ aqueous fluid of ocular tuberculosis patients. | Indian Council of Medical Research | 2023-2026 | Dr Himanshu Behera |
| 8 | Investigating a crystiInvestigating a-crystallin-particulate matter interactions to assess the impact of air pollution on ocular protein homeostasis | Indian Council of Medical Research | 2023-2026 | Dr Inderjeet Kaur |
| 9 | Development of intraocular implant providing controlled and localized combination drug therapy- towards efficacious treatment of diabetic retinopathy | Indian Council of Medical Research | 2023-2026 | Dr Inderjeet Kaur |
| 10 | Sustained dual drug release of Timolol Maleate and Latanoprost for Glaucoma Treatment: In vivo studies towards cross-linker free drug-polymer formulation for usage as eye drop
| Indian Council of Medical Research | 2025-2028 | Dr Inderjeet Kaur |
| 11 | Generation and evaluation of universal donor stem cells for applications in allogenic cell therapy for retinal dystrophic conditions
| Indian Council of Medical Research | 2022-2025 | Dr Indumathi Mariappan |
| 12 | Clinical utility of Extracellular Vesicles as a miRNA delivery carrier for the treatment of Mutidrug Resistant Endophthalmitis | Indian Council of Medical Research | 2024-2027 | Dr Joveeta Joseph |
| 13 | Proof of Concept study of effects of Plazomicin on Islotes from Bacterial Keratitis and /or Conjuctivitis | CIPLA
| 2023-2025 | Dr Joveeta Joseph |
| 14 | J C Bose | Science and Engineering Research Board | 2023-2028 | Dr Mohammad Javed Ali |
| 15 | Role of TET family proteins in Retinoblastoma | Indian Council of Medical Research | 2023-2026 | Dr Mamatha Reddy |
| 16 | Fatty Acid desaturrase inhibition as a therapeutic statergy to restrict retinoblastoma tumor cell growth and proliferation
| Indian Council of Medical Research | 2024- 2027 | Dr Mamatha Reddy |
| 17 | New therapeutic approach for corneal dystrophy via CRISPR mediated SLC4A11 gene correction in an in-vitro and in-vivo system using advanced cRGD decorated lipo-polymeric nanoplexes | Science and Engineering Research Board | 2024-2027 | Dr Muralidhara Ramappa |
| 18 | An Evaulation of the effectivness of contact lenses utilising S.T.O.P technology in slowing dowm myopia progression | STOP
| 2022-2025 | Dr Pavan K. Verkicharla |
| 19 | WOMBAT- Spectacle Film Study | NTHALMIC PVT LTD
| 2024-2026 | Dr Pavan K. Verkicharla |
| 20 | Baby Vision Screener (BaViS): A device to screen visual cognitive milestones in early childhood | Indian Council of Medical Research | 2023-2025 | Dr PremNandhini Satgunam |
| 21 | Development of Automated Gaze Detection of Babies to study Visual Cognition | Department of Biotechnology | 2024-2027
| Dr Prem Nandhini Satgunam |
| 22 | Artificial Intelligence enabled referral pathways for early diagnosis of complications arising from diabetes: application to diabetic retinopathy | Indian Council of Medical Research | 2024-2027 | Dr Padmaja K Rani |
| 23 | Biological and molecular understanding of chemotherapy resistance and metastasis in Retinoblastoma | Ramalingaswami re entry Fellowship | 2024-2027 | Dr Pallavi Rani |
| 24 | Evaluation and Characterization of Tear-Derived Small Extracellular Vesicles for Prognostication and Genetic Insights in Retinoblastoma | Anusandhan National Research Foundation | 2025-2028 | Dr Pallavi Rani |
| 25 | Therapeutic and immunomodulatoryeffects of human limbus-derivedmesenchymal stem cells in a rat model ofallergic conjunctivitis
| Indian Council of Medical Research | 2023-2026 | Dr Pragnya Rao |
| 26 | Biomimetic corneal patch for treating fungal keratitis | Indian Council of Medical Research | 2023-2026 | Dr Prashant Garg |
| 27 | Antibiotic loaded corneal device: A platform delivery system to tackle ophthalmic infections | Velux Stiftung | 2025-2028 | Dr Prashant Garg |
| 28 | Ecofriendly Biofilm Inhibiting Coatings on Hernia Repair Meshes for Prevention of Surgical Site Infections | Department of Science and Technology | 2025-2027 | Dr Prashant Garg |
| 29 | Centre for Advanced Research in Ocular Drug Delivery Devices: Developing Stable Platforms for Extemporaneous Antimicrobials to Counteract Antimicrobial Resistance (AMR)
| Indian Council of Medical Research | 2025-2028 | Dr Prashant Garg |
| 30 | Exploring potential interplay of tear cytokine levels and confocal biomicroscopy in progressive keratoconus for better clinical diagnosis-SRG | Science and Engineering Research Board | 2024-2026 | Dr Rashmi Deshmukh |
| 31 | Cell-based therapy for lacrimal gland regeneration and repair in a preclinical animal model of aqueous deficiency dry eye disease | Wellcome Trust India Alliance-Early Career | 2023-2028 | Dr Swati Singh |
| 32 | Preclinical development of long acting subconjuncyival steriod sparing agent to treat posterior uveitis | Indian Council of Medical Research | 2023-2026 | Dr Soumyava Basu |
| 33 | Understanding the role of gasdermin D in the pathogenesis of mucormycosis-CRG | Science and Engineering Research Board | 2023-2026 | Dr Sanhita Roy |
| 34 | Rational design and structure-function analysis of antimicrobial peptides tailored to treat fungal ocular infections | Velux Stiftung Foundation-Switerland | 2023-2026 | Dr Sanhita Roy |
| 35 | Adult Mesenchymal stem cells as adjuctive therapy for bacterial keratitis: A novel approach to treat corneal infections
| Indian Council of Medical Research | 2022-2025 | Dr Sachin Shukla |
| 36 | Vision loss, disability, and multimorbidity among the elderly population in Telangana, India - The Longitudinal Eye Health Aging and Disability Study (LEADS) | Wellcome Trust India Alliance | 2023-2028 | Dr Srinivas Marmamula |
| 37 | Exploring variation in humans ability to free -fuse targets for cyclopean visual experience | DST- Cognitive Science Research Initiative | 2023-2026 | Dr Shrikant Bharadwaj |
| 38 | Tensor-based Machine Learning for Early Detection of Keratoconus | AI4ICPS | 2024-2026 | Dr Shrikant Bhadrawaj |
| 39 | NAYAM Innovations | NAYAM | 2025-2026 | Dr Shrikant Bhadrawaj |
| 40 | Investigating the static and dynamic Characteristics of accommodation as a marker to differentiate “pseudo myopia from true axial myopia
| Essilor Essilor Corporation | 2025-2027 | Dr Shrikant Bhadrawaj |
| 41 | Biomimetic hydrogel for the treatment of blinding corneal diseases | SREE PVF | 2022-2025 | Dr Sayan Basu |
| 42 | Improving Corneal Healing Via Modulation of Tissues | Ulverscroft Foundation | 2019-2026 | Dr Sayan Basu |
| 43 | Corneal Characterization under biaxial loading in physiological conditions-CRG | Science and Engineering Research Board | 2023-2026 | Dr Sayan Basu |
| 44 | A device based on digital photo elasticity for in-vivo characterization of corneal birefringence | Department of Biotechnology | 2024-2027 | Dr Sayan Basu |
| 45 | To investigate limbal biology in Stevens-Johnson Syndrome (SJS) and develop various animal models of SJS pathology. | Velux Stiftung | 2025-2029 | Dr Sayan Basu |
| 46 | 3D Bioprinted Corneal Stroma for Partial Keratoplasty: A Step Toward Restoring Vision | Indian Council of Medical Research - First in the world | 2025-2028 | Dr Sayan Basu |
| 47 | Phase I/II Multicenter Randomized Controlled Clinical Trial of Mesenchymal Stem Cell Therapy for Severe Ocular Surface Chemical injury - University of Illinois- Chicago
| University of Illinois - Chicago | 2024-2026 | Dr Sayan Basu |
| 48 | Investigating the potential cross talk between mitochondrial and nuclear gene in primary open angle glaucoma | Indian Council of Medical Research | 2023-2026 | Dr Subhabrata Chakrabarti |
| 49 | Therapeutic potential of decellularized cornea matrix (DCM) hydrogel for corneal scars and stromal replacement in trauma conditions: Pre-clinical study | Indian Council of Medical Research | 2022-2025 | Dr Vivek Singh |
| 50 | Biomaterial and cell based therapy for corneal blindness | Department of Biotechnology ( TATA innovation program) | 2024-2027 | Dr Vivek Singh |
| 51 | Preclinical and phase 0/1 clinical investigation of minimally invasive microneedle patch for effective chemotherapy in Retinoblastoma | Indian Council of Medical Research | 2023-2026 | Dr Vishal R Raval |
| 52 | Development of multimodal optical coherence tomography ultrasound MEMS technology-based microscopic-resolution photo acoustic elastography (OCT-US-MEMS-μPAE) imaging system: a validation study for ophthalmic diagnosis and therapeutic treatments | Department of Biotechnology | 2024-2027 | Dr Vishal Raval
|
| 53 | Subretinal Fluid in Coats’ Disease: Biochemical composition and association of lipid-laden macrophages with inflammatory biomarkers | Jack McGovern Coats' Disease Foundation | 2024-2025 | Dr Vishal Raval |
